Collagen Matrix, Inc. is a leader in the design and engineering of collagen- and mineral-based extracellular matrices for tissue and organ repair and regeneration. Since its inception in 1997, the Company has received many government grants for the development of innovative, collagen-based matrix products in the areas of neurological, vascular, urological, and orthopedic tissue regeneration applications. The Company currently manufactures collagen-based finished medical devices in the areas of oral/maxillofacial surgery, neurosurgery, and orthopedic-spine surgery.
The transaction allows the Company to accelerate the commercialization of revolutionary OssiMend™ Bone Graft Matrix and DuraMatrix-Onlay™ Conformable Collagen Dura Substitute Membrane products, in addition to a new family of products for oral surgery. The investment will also support the expansion of a world-class 28,000 sq. ft. manufacturing facility.
If you would like to learn more information about this transaction contact us below.